SaaS player MedAdvisor Ltd raises $17 million for growth push

MedAdvisor is a little-known tech and healthcare small cap.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Digital medication management company MedAdvisor Ltd (ASX: MDR) last week announced it has raised $17 million by issuing 340 million new shares at an issue price of 5 cents per share. That actually represented an 11% premium to its last pre-cap raising trading price of 4.5 cents per share.

Nasdaq-listed US healthcare operator HMS Holdings Corp (HMSY) is a cornerstone investor in the capital raising by agreeing to tip in $11 million.

“Funds raised will accelerate international expansion through MedAdvisor’s synergistic partnering strategies in the US, South East Asia and the UK, as well as driving domestic growth through sales, marketing and technology development taking the business towards cash break even,” Medadvisor reported. 

As part of the deal MedAdvisor also reports it will become HMS’s “preferred partner” for the distribution of digital health software-as-a-service products in the US and Australia. 

MedAdvisor claims to have connected more than 1 million patients already via a network of around 55% of all Australian pharmacies. 

For the fiscal year ending June 30 2019 it reported a net loss of $8.15 million on sales of $8.24 million and total revenue of  $9.2 million.

It recently recruited the ex Redbubble Ltd (ASX: RBL) chief technology officer to take up the role at MedAdvisor. 

As at September 2 2019 it had 1.37 billion shares on issue, with another 340 million issued as a result of the capital raising. As a result it looks to have a market value around $85 million based on around 1.71 billion shares on issue. 

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has recommended MedAdvisor and REDBUBBLE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two hands being shaken symbolising a deal.
Mergers & Acquisitions

How many global mega deals involved ASX 200 shares in the first half of 2022?

Deal making among ASX 200 shares helped drive a 25.4% increase in M&A activity in Australia in the first half…

Read more »

Top 10 blank list on chalkboard
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

a man peers between two large piles of papers and files with a wide-eyed, wide-mouth look of dread at the amount of work he has to do.
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Wednesday

We take a look at the most traded ASX 200 shares by volume today.

Read more »

workers stand over a large spool of copper pipe.
Share Market News

ASX copper shares in the red as copper price sinks to 19 month low

Copper prices fell in global markets overnight.

Read more »

Man with rocket wings which have flames coming out of them.
Share Market News

EML share price leaps 16% on Spanish government stimulus contract

EML shares are on fire on Wednesday...

Read more »

Share Market News

ASX 200 midday update: BHP and Fortescue sink, EML and ZIP jump

The ASX 200 is having a difficult day due to weakness in the mining sector...

Read more »

Business woman watching stocks and trends while thinking
Share Market News

5 things to watch on the ASX 200 on Wednesday

The ASX 200 looks set to have a tough day on Wednesday...

Read more »

Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »